Anthropic has entered the AI healthcare race with a new drug discovery program focused on neglected diseases while also ...
June 29 (Reuters) - BioCryst Pharmaceuticals said on Monday it would wind down its internal drug discovery programs and close its Alabama research facility by the end of 2026, as it pivots to external ...
Anthropic announced Tuesday that it is launching new pre-clinical drug discovery programs in an attempt to produce artificial ...
Anthropic has launched a drug discovery program targeting neglected diseases and introduced Claude Science, an AI platform ...
LEBANON, N.H.--(BUSINESS WIRE)-- Adimab, LLC, a technology leader in the discovery of fully human antibodies, today announced the initiation of two independent collaborations with Biogen Idec and Novo ...
Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth- ...
Yuva Biosciences' proprietary MitoNova™ AI platform identified small-molecule candidates that were biologically validated in primary human skeletal muscle cells, with multiple candidates increasing ...